Gene "DCLK2"
Found 1 record
Gene information
Gene symbol:
DCLK2
See related:
Ensembl: ENSG00000170390, Gene ID: 166614
Additive variants :
Detected
Genetic interaction partners
Confidence      Stringent (ε>0.16 or ε<-0.12)      Intermediate (-0.16≤ε≤-0.08 or 0.08≤ε≤0.16)      Lenient (|ε|<0.08)
Positive interactions
  • ATAD2 
  • SIN3A 
  • MAP3K2 
  • MRPL36 
  • TIMM13 
  • PDHA2 
  • PGAP1 
  • PPP6R3 
  • ACTR6 
  • IMMP2L 
  • MARCH6 
  • GGPS1 
  • DDX21 
  • CHN1 
  • NUDT5 
  • MIOS 
  • WDR59 
  • VPS13D 
  • STRIP2 
  • PIGG 
  • PPCDC 
  • OVCA2 
  • NFXL1 
  • ALG8 
  • SLC3A1 
  • SLC27A3 
  • ZDHHC6 
  • PEX12 
  • VAC14 
  • OGFOD1 
  • WWOX 
  • NTHL1 
  • PGM1 
  • HHATL 
  • CTU1 
  • CHD8 
  • ABCC6 
  • ERCC6 
  • CRY2 
  • DDX31 
  • COQ7 
  • DPP6 
  • CORO2B 
  • CLPB 
  • MSRA 
  • ALG12 
  • PPP6R3 
  • PSMD4 
  • PRKG2 
  • ALDH1L2 
  • IDH2 
  • POMT2 
  • TUBA3D 
  • PNP 
  • ATG7 
  • RPS28 
  • EIF5A2 
  • MOGAT3 
  • CLK2 
  • SLC35B1 
  • SLC44A3 
  • ZMPSTE24 
  • PSPH 
  • ASH1L 
  • THADA 
  • ACER3 
Negative interactions
  • CCNA2 
  • RAD17 
  • ATP1A1 
  • SBK1 
  • SFN 
  • TIA1 
  • MRM2 
  • NPLOC4 
  • CSNK2B 
  • BUD31 
  • TGS1 
  • NAA30 
  • CDC73 
  • WRN 
  • CLIP1 
  • XRN1 
  • PBLD 
  • DNAJC17 
  • DNAJA4 
  • KIFC2 
  • DYNC2H1 
  • ASF1A 
  • H3F3C 
  • TTF2 
  • RAB6B 
  • DDI2 
  • TXNDC9 
  • USP4 
  • GLIPR2 
  • MRI1 
  • TTC31 
  • DGAT1 
  • SLC25A28 
  • RAD52 
  • SMARCB1 
  • SLC38A7 
  • HORMAD1 
  • NIF3L1 
  • OTUD6A 
  • RCOR1 
  • PHB2 
  • SRPK2 
  • ENPP2 
  • KTI12 
  • SEC24D 
  • RHOH 
  • ZFP42 
  • PPP6R3 
  • ELOVL1 
  • DYNLL1 
  • PRDX6 
  • SLC12A8 
  • EXO1 
  • FOXJ3 
  • PPCDC 
  • QPRT 
  • RPS7 
  • HIST2H4B 
  • HNRNPM 
  • MGLL 
  • RPL7A 
  • DPYSL2 
  • TALDO1 
  • LSM14B 
  • PAN2 
  • SDSL 
  • LETM1 
  • ZFP36L2 
Modifier statisitcs
Record:
Disorder:
Vriant:
Reference:
Effect type:
Expressivity(1)  
Modifier effect:
Altered severity(1)  
Detail:
  • Variant 1:
    Gene:
    Genomic location:
    dbSNP ID:
    Target disease:
    Effect type:
    Expressivity 
    Modifier effect:
    Altered severity 
    Evidence:
    Pedigree analysis 
    Effect:
    The polymorphism is associated with the disease severity.
    Reference:
    Title:
    Novel mutations in the DYNC1H1 tail domain refine the genetic and clinical spectrum of dyneinopathies.
    Species studied:
    Human
    Abstract:
    The heavy chain 1 of cytoplasmic dynein (DYNC1H1) is responsible for movement of the motor complex along microtubules and recruitment of dynein components. Mutations in DYNC1H1 are associated with spinal muscular atrophy (SMA), hereditary motor and sensory neuropathy (HMSN), cortical malformations, or a combination of these. Combining linkage analysis and whole-exome sequencing, we identified a novel dominant defect in the DYNC1H1 tail domain (c.1792C>T, p.Arg598Cys) causing axonal HMSN. Mutation analysis of the tail region in 355 patients identified a de novo mutation (c.791G>T, p.Arg264Leu) in an isolated SMA patient. Her phenotype was more severe than previously described, characterized by multiple congenital contractures and delayed motor milestones, without brain malformations. The mutations in DYNC1H1 increase the interaction with its adaptor BICD2. This relates to previous studies on BICD2 mutations causing a highly similar phenotype. Our findings broaden the genetic heterogeneity and refine the clinical spectrum of DYNC1H1, and have implications for molecular diagnostics of motor neuron diseases.